Insider Selling: Phreesia, Inc. (NYSE:PHR) COO Sells 2,873 Shares of Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 2,873 shares of the company’s stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $26.61, for a total value of $76,450.53. Following the transaction, the chief operating officer now directly owns 779,993 shares in the company, valued at approximately $20,755,613.73. This represents a 0.37 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Evan Roberts also recently made the following trade(s):

• On Tuesday, October 15th, Evan Roberts sold 1,843 shares of Phreesia stock. The stock was sold at an average price of $21.03, for a total value of $38,758.29.

Phreesia Stock Up 5.3 %

Shares of PHR stock opened at $28.42 on Thursday. The company has a current ratio of 1.74, a quick ratio of 1.77 and a debt-to-equity ratio of 0.04. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $29.16. The stock has a 50 day moving average of $22.50 and a 200 day moving average of $22.53. The stock has a market cap of $1.65 billion, a P/E ratio of -19.33 and a beta of 0.94.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Monday, December 9th. The company reported ($0.25) EPS for the quarter, beating the consensus estimate of ($0.29) by $0.04. The company had revenue of $106.80 million for the quarter, compared to analyst estimates of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. Phreesia’s quarterly revenue was up 16.6% compared to the same quarter last year. During the same period last year, the company earned ($0.58) earnings per share. As a group, sell-side analysts expect that Phreesia, Inc. will post -1.16 EPS for the current year.

Institutional Investors Weigh In On Phreesia

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Franklin Resources Inc. lifted its holdings in Phreesia by 3.0% during the third quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock valued at $31,495,000 after purchasing an additional 42,973 shares in the last quarter. Geode Capital Management LLC lifted its stake in Phreesia by 4.7% in the 3rd quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock valued at $28,397,000 after buying an additional 55,934 shares in the last quarter. M&T Bank Corp lifted its stake in Phreesia by 4.6% in the 3rd quarter. M&T Bank Corp now owns 35,127 shares of the company’s stock valued at $801,000 after buying an additional 1,535 shares in the last quarter. Barclays PLC boosted its holdings in Phreesia by 83.6% in the 3rd quarter. Barclays PLC now owns 94,929 shares of the company’s stock worth $2,163,000 after buying an additional 43,225 shares during the last quarter. Finally, XTX Topco Ltd purchased a new stake in Phreesia during the 3rd quarter worth approximately $247,000. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on PHR shares. Robert W. Baird dropped their price objective on Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research note on Wednesday, December 11th. Needham & Company LLC reiterated a “buy” rating and set a $29.00 price objective on shares of Phreesia in a research note on Tuesday, December 10th. Royal Bank of Canada upgraded Phreesia from a “sector perform” rating to an “outperform” rating and increased their price target for the company from $24.00 to $32.00 in a research note on Wednesday. JMP Securities reiterated a “market outperform” rating and set a $30.00 price objective on shares of Phreesia in a research note on Tuesday, December 10th. Finally, KeyCorp lifted their target price on Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a report on Wednesday. Eleven analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $30.64.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.